CTRN - ALT LFCR and CNTB among pre market losers
2023-03-21 08:20:25 ET
- Altimmune ( ALT ) -37% announces positive results from week 24 interim analysis of Pemvidutide MOMENTUM phase 2 obesity trial and 12-Week phase 1b type 2 diabetes safety trial.
- First Majestic Silver ( AG ) -14% suspends mining at Jerritt Canyon as costs climb.
- Connect Biopharma Holdings ( CNTB ) -12% .
- Lifecore Biomedical ( LFCR ) -6% .
- Ambipar Emergency Response ( AMBI ) -6% .
- Hub Cyber Security ( HUBC ) -6% .
- Citi Trends ( CTRN ) -6% on Q4 earnings.
For further details see:
ALT, LFCR and CNTB among pre market losers